SpicyIP Tidbits: WHO and DCGI- A Sweet-Sour Relationship
In what seems to have become a regular affair, the WHO has “has objected to the practice of Indian pharmaceutical companies misusing international non-proprietary names (INN) as trademark protected brand names.” If newspaper reports are to be believed…: “In a recent letter to the Drugs Controller General of India (DCGI), the WHO has expressed concern over a trademark application filed by Cadila Pharmaceuticals for “platin”, a common name that is used for at least 18 medicines. Cadilla officials were not […]
SpicyIP Tidbits: WHO and DCGI- A Sweet-Sour Relationship Read More »


